University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Pancreas Cancer Program

M.TemperoProgram Leader: Margaret Tempero, MD
Director, UCSF Pancreas Center; Leader, Pancreas Cancer Program;
Professor of Medicine, Division of Hematology and Oncology, UCSF

Rombauer Family Distinguished Professorship in Pancreas Cancer Clinical and Translational Science

> UCSF clinical care for pancreas cancer
> Pancreas cancer clinical trials at UCSF

Latest News

UCSF Pancreas Cancer NewsThe 2018 edition of Pancreas Cancer News at UCSF features spotlights on clinical research, care, and donors.


Newsletter Archive

Pancreatic cancer is the fourth most common cause of cancer death in the United States. The American Cancer Society estimates that in 2015 about 48,960 people will be newly diagnosed with pancreatic cancer and more than 40,560 people will die from the disease. Pancreatic cancer is a silent killer, as its symptoms are so insidious that most people are not diagnosed until the disease has advanced beyond the stage where surgical resection is possible. Even among surgical candidates, removal of the diseased pancreas and surrounding tissues is rarely curative. To add to this bleak picture, pancreas cancer is also noted for its intrinsic resistance to standard regimens of chemo- and radiotherapy. It is clear that new strategies to prevent, diagnose, and treat pancreas cancer are urgently required.